111, Inc. Sponsored ADR (NASDAQ:YI) Short Interest Update

111, Inc. Sponsored ADR (NASDAQ:YI) was the target of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 9,363 shares, a growth of 107.5% from the June 30th total of 4,513 shares. Based on an average daily volume of 17,270 shares, the short-interest ratio is currently 0.5 days. Currently, 0.2% of the company’s shares are sold short.

111 Stock Performance

Shares of NASDAQ:YI opened at $3.64 on Friday. 111 has a 52-week low of $2.48 and a 52-week high of $11.17. The business’s 50 day simple moving average is $4.34 and its two-hundred day simple moving average is $5.82. The firm has a market cap of $31.99 million, a P/E ratio of -2.60 and a beta of 0.63.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, July 2nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, 111 presently has a consensus rating of “Sell”.

Insiders Place Their Bets

In other 111 news, Director Jian David Sun sold 111,100 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $0.23, for a total value of $25,553.00. Following the transaction, the director directly owned 472,011 shares of the company’s stock, valued at approximately $108,562.53. The trade was a 19.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 595,540 shares of company stock valued at $141,105 in the last ninety days. Insiders own 43.90% of the company’s stock.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.